M
Mediplantex National Pharmaceutical JSC
VN:MED
Mediplantex National Pharmaceutical JSC
VN:MED
Price:
27 800
VND
-9.74%
Market Cap:
₫345B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
VN |
|
MTU Aero Engines AG
XETRA:MTX
|
DE |
|
Pharmacielo Ltd
XTSX:PCLO
|
CA |
|
Atco Ltd
TSX:ACO.Y
|
CA |
|
Huafa Property Services Group Co Ltd
HKEX:982
|
HK |
Income Statement
Earnings Waterfall
Mediplantex National Pharmaceutical JSC
Mediplantex National Pharmaceutical JSC
Income Statement
Mediplantex National Pharmaceutical JSC
Mediplantex National Pharmaceutical JSC
Currency: VND
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
4 452
|
4 383
|
4 353
|
5 004
|
5 756
|
6 017
|
5 885
|
5 394
|
4 912
|
4 655
|
4 533
|
3 787
|
3 111
|
0
|
0
|
0
|
|
| Revenue |
322 829
N/A
|
322 319
0%
|
351 520
+9%
|
401 051
+14%
|
409 334
+2%
|
407 712
0%
|
405 388
-1%
|
402 741
-1%
|
420 824
+4%
|
465 112
+11%
|
451 272
-3%
|
443 136
-2%
|
413 604
-7%
|
360 486
-13%
|
355 389
-1%
|
367 081
+3%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(263 761)
|
(262 270)
|
(288 168)
|
(322 635)
|
(327 723)
|
(327 625)
|
(323 364)
|
(319 663)
|
(334 059)
|
(371 252)
|
(358 195)
|
(350 574)
|
(325 588)
|
(276 434)
|
(274 655)
|
(281 807)
|
|
| Gross Profit |
59 068
N/A
|
60 049
+2%
|
63 352
+6%
|
78 416
+24%
|
81 611
+4%
|
80 087
-2%
|
82 024
+2%
|
83 078
+1%
|
86 766
+4%
|
93 860
+8%
|
93 077
-1%
|
92 561
-1%
|
88 016
-5%
|
84 052
-5%
|
80 735
-4%
|
85 274
+6%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(54 572)
|
(53 948)
|
(55 291)
|
(65 968)
|
(63 715)
|
(61 054)
|
(63 146)
|
(62 362)
|
(62 860)
|
(69 544)
|
(68 702)
|
(70 268)
|
(68 589)
|
(66 382)
|
(62 977)
|
(64 240)
|
|
| Selling, General & Administrative |
(55 564)
|
(54 413)
|
(55 816)
|
(66 277)
|
(64 623)
|
(65 023)
|
(68 172)
|
(66 592)
|
(67 154)
|
(70 712)
|
(68 389)
|
(68 220)
|
(67 317)
|
(65 690)
|
(62 877)
|
(64 155)
|
|
| Depreciation & Amortization |
(3 437)
|
(3 297)
|
(3 223)
|
(3 054)
|
(2 790)
|
(2 569)
|
0
|
(2 305)
|
(1 732)
|
(1 584)
|
(2 355)
|
(2 148)
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
4 429
|
3 762
|
3 748
|
3 362
|
3 697
|
6 538
|
5 026
|
6 535
|
6 026
|
2 753
|
2 041
|
100
|
(1 273)
|
(692)
|
(101)
|
(85)
|
|
| Operating Income |
4 496
N/A
|
6 101
+36%
|
8 060
+32%
|
12 448
+54%
|
17 896
+44%
|
19 033
+6%
|
18 878
-1%
|
20 716
+10%
|
23 906
+15%
|
24 316
+2%
|
24 375
+0%
|
22 293
-9%
|
19 426
-13%
|
17 670
-9%
|
17 757
+0%
|
21 034
+18%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(4 452)
|
(4 383)
|
(4 353)
|
(5 004)
|
(5 756)
|
(6 017)
|
(5 885)
|
(5 394)
|
(4 912)
|
(4 655)
|
(4 533)
|
(3 787)
|
(3 111)
|
(2 614)
|
(2 149)
|
(2 218)
|
|
| Non-Reccuring Items |
(2 159)
|
(1 652)
|
(1 652)
|
0
|
(16)
|
(25)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(250)
|
23
|
0
|
0
|
(23)
|
(208)
|
0
|
0
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(2 312)
|
(2 342)
|
(2 329)
|
793
|
2 444
|
2 444
|
2 230
|
(399)
|
(514)
|
863
|
779
|
928
|
1 031
|
(146)
|
(110)
|
1 133
|
|
| Pre-Tax Income |
(4 677)
N/A
|
(2 253)
+52%
|
(274)
+88%
|
8 236
N/A
|
14 546
+77%
|
15 228
+5%
|
15 224
0%
|
14 923
-2%
|
18 480
+24%
|
20 525
+11%
|
20 621
+0%
|
19 418
-6%
|
17 346
-11%
|
14 909
-14%
|
15 499
+4%
|
19 950
+29%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(544)
|
(456)
|
(848)
|
(2 214)
|
(2 556)
|
(3 341)
|
(3 331)
|
(3 179)
|
(3 877)
|
(4 281)
|
(4 310)
|
(4 171)
|
(3 748)
|
(3 237)
|
(3 399)
|
(4 678)
|
|
| Income from Continuing Operations |
(5 221)
|
(2 709)
|
(1 121)
|
6 022
|
11 990
|
11 887
|
11 893
|
11 744
|
14 603
|
16 244
|
16 312
|
15 247
|
13 598
|
11 673
|
12 100
|
15 272
|
|
| Net Income (Common) |
(5 221)
N/A
|
(2 709)
+48%
|
(1 121)
+59%
|
6 022
N/A
|
11 990
+99%
|
11 887
-1%
|
11 893
+0%
|
11 744
-1%
|
14 603
+24%
|
16 244
+11%
|
16 312
+0%
|
15 247
-7%
|
13 598
-11%
|
11 673
-14%
|
12 100
+4%
|
15 272
+26%
|
|
| EPS (Diluted) |
-831.54
N/A
|
-216.55
+74%
|
-119.38
+45%
|
553.61
N/A
|
1 099.94
+99%
|
853.96
-22%
|
958.35
+12%
|
946.32
-1%
|
1 176.71
+24%
|
1 308.93
+11%
|
1 314.39
+0%
|
1 228.59
-7%
|
1 095.71
-11%
|
940.57
-14%
|
975
+4%
|
1 230.6
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
